RxDoctor Payments Data

John Custer, MD

Psychiatry · Charleston, SCNPI 1578679452

Payments from drug & device makers

$3,464in general payments, 2019–2025

Across 178 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$658
  • Alkermes, Inc.$526
  • Otsuka America Pharmaceutical, Inc.$455
  • Takeda Pharmaceuticals U.S.A., Inc.$377
  • Johnson & Johnson$329
  • Axsome Therapeutics, Inc.$312
  • plus $808 from 11 others

What the payments were for

  • Food & beverage$3,464100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,464 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$28,399
Medicare patients
76
Services billed
452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine23$274,361
IngrezzaValbenazine Tosylate17$135,953
Invega SustennaPaliperidone Palmitate24$61,812
Abilify MaintenaAripiprazole17$49,352
UzedyRisperidone18$36,787
BelsomraSuvorexant43$16,564
ConcertaMethylphenidate Hcl24$10,454
TrintellixVortioxetine Hydrobromide20$9,414
Seroquel XrQuetiapine Fumarate12$7,708
DayvigoLemborexant12$3,887
Aripiprazole115$3,866
Haloperidol Decanoate71$3,774
Divalproex Sodium ErDivalproex Sodium82$2,115
Duloxetine Hcl117$2,077
Venlafaxine Hcl ErVenlafaxine Hcl84$1,831

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo, Uzedy$658$311,14841 claims
Neurocrine Biosciences, Inc.Ingrezza$88$135,95317 claims
Johnson & JohnsonInvega Sustenna, Concerta$329$72,26648 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$455$49,35217 claims
MerckBelsomra$13$16,56443 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$377$9,41420 claims
Eisai Inc.Dayvigo$72$3,88712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →